loadpatents
name:-0.013328075408936
name:-0.020124197006226
name:-0.0006718635559082
Robbins; John B. Patent Filings

Robbins; John B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Robbins; John B..The latest application filed is for "use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax".

Company Profile
1.45.36
  • Robbins; John B. - New York NY
  • Robbins; John B. - New York City NY
  • Robbins; John B. - Chevy Chase MD US
  • Robbins; John B. - Bethesda MD
  • Robbins; John B. - McKinney TX
  • Robbins; John B. - Sherman TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Vibrio cholerae O139 conjugate vaccines
Grant 9,173,932 - Szu , et al. November 3, 2
2015-11-03
Vaccine for Shigella
Grant 9,144,604 - Robbins , et al. September 29, 2
2015-09-29
Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
Grant 9,096,653 - Schneerson , et al. August 4, 2
2015-08-04
Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax
App 20150093412 - Kubler-Kielb; Joanna ;   et al.
2015-04-02
Conjugates Of Plasmodium Falciparum Surface Proteins As Malaria Vaccines
App 20150050314 - Schneerson; Rachel ;   et al.
2015-02-19
Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax
Grant 8,926,986 - Kubler-Kielb , et al. January 6, 2
2015-01-06
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
Grant 8,900,599 - Schneerson , et al. December 2, 2
2014-12-02
Vibrio cholerae O139 conjugate vaccines
Grant 8,852,605 - Szu , et al. October 7, 2
2014-10-07
Vibrio Cholerae 0139 Conjugate Vaccines
App 20140287476 - Szu; Shousun Chen ;   et al.
2014-09-25
Vaccine For Shigella
App 20140242666 - Robbins; John B. ;   et al.
2014-08-28
Vaccines Against Influenza Virus
App 20140205622 - Miller; Mark A. ;   et al.
2014-07-24
Vaccine for shigella
Grant 8,747,863 - Robbins , et al. June 10, 2
2014-06-10
Methods of using Bacillus anthracis protective antigen sequences for vaccination
Grant 8,703,150 - Leppla , et al. April 22, 2
2014-04-22
Vaccines against influenza virus
Grant 8,658,180 - Miller , et al. February 25, 2
2014-02-25
Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax
App 20130273097 - Kubler-Kielb; Joanna ;   et al.
2013-10-17
Multicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia
App 20130216570 - Schneerson; Rachel ;   et al.
2013-08-22
Methods for preparing immunogenic conjugates
Grant 8,481,048 - Schneerson , et al. July 9, 2
2013-07-09
Conjugates Of Plasmodium Falciparum Surface Proteins As Malaria Vaccines
App 20130129777 - Schneerson; Rachel ;   et al.
2013-05-23
Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
Grant 8,444,996 - Schneerson , et al. May 21, 2
2013-05-21
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
Grant 8,394,387 - Leppla , et al. March 12, 2
2013-03-12
Recombinant Modified Bacillus Anthracis Protective Antigen For Use In Vaccines
App 20130058967 - Leppla; Stephen H. ;   et al.
2013-03-07
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
Grant 8,383,133 - Schneerson , et al. February 26, 2
2013-02-26
Alignment mark for opaque layer
Grant 8,324,742 - Summerfelt , et al. December 4, 2
2012-12-04
Alignment mark for opaque layer
Grant 8,268,696 - Summerfelt , et al. September 18, 2
2012-09-18
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
Grant 8,202,520 - Kossaczka , et al. June 19, 2
2012-06-19
Vaccines against Escherichia coli O157 infection
Grant 8,168,195 - Szu , et al. May 1, 2
2012-05-01
Bacillus Anthracis Protective Antigen Sequences
App 20120009219 - Leppla; Stephen H. ;   et al.
2012-01-12
Alignment Mark For Opaque Layer
App 20110306176 - Summerfelt; Scott R. ;   et al.
2011-12-15
Bacillus anthracis protective antigen nucleic acid sequences
Grant 8,044,189 - Leppla , et al. October 25, 2
2011-10-25
Vaccine For Shigella
App 20110212125 - Robbins; John B. ;   et al.
2011-09-01
Multicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia
App 20110182929 - Schneerson; Rachel ;   et al.
2011-07-28
Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax
App 20100330074 - Kubler-Kielb; Joanna ;   et al.
2010-12-30
Bacillus Anthracis Protective Antigen Nucleic Acid Sequences
App 20100272757 - Leppla; Stephen H. ;   et al.
2010-10-28
Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
Grant 7,803,386 - Schneerson , et al. September 28, 2
2010-09-28
Method Of Immunizing Humans Against Salmonella Typhi Using A Vi-repa Conjugate Vaccine
App 20100239601 - Kossaczka; Zuzana ;   et al.
2010-09-23
Methods for preparing Bacillus anthracis protective antigen for use in vaccines
Grant 7,763,451 - Shiloach , et al. July 27, 2
2010-07-27
Conjugates Of Plasmodium Falciparum Surface Proteins As Malaria Vaccines
App 20100183678 - Schneerson; Rachel ;   et al.
2010-07-22
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
Grant 7,754,227 - Kossaczka , et al. July 13, 2
2010-07-13
Vaccines Against Influenza Virus
App 20100150954 - Miller; Mark A. ;   et al.
2010-06-17
Cholesterol-containing Compounds And Their Use As Immunogens Against Borrelia Burgdorferi
App 20100062023 - Ben-Menachem; Gil ;   et al.
2010-03-11
Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
Grant 7,666,846 - Ben-Menachem , et al. February 23, 2
2010-02-23
Methods For Preparing Immunogenic Conjugates
App 20100040644 - Schneerson; Rachel ;   et al.
2010-02-18
Methods for preparing immunogenic conjugates
Grant 7,625,736 - Schneerson , et al. December 1, 2
2009-12-01
Alignment Mark For Opaque Layer
App 20090243122 - Summerfelt; Scott R. ;   et al.
2009-10-01
Vaccines Against Escherichia Coli O157 Infection
App 20090232840 - Szu; Shousun Chen ;   et al.
2009-09-17
Vaccines against Escherichia coli O157 infection
Grant 7,553,490 - Szu , et al. June 30, 2
2009-06-30
Vibrio cholerae 0139 conjugate vaccines
Grant 7,527,797 - Szu , et al. May 5, 2
2009-05-05
Antimultiorganism glycoconjugate vaccine
Grant 7,422,755 - Kubler-Kielb , et al. September 9, 2
2008-09-09
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
Grant 7,261,900 - Leppla , et al. August 28, 2
2007-08-28
Method of immunizing humans against salmonella typhi using a Vi-rEPA conjugate vaccine
App 20070172501 - Kossaczka; Zuzana ;   et al.
2007-07-26
Vaccines against Escherichia coli O157 infection
Grant 7,247,307 - Szu , et al. July 24, 2
2007-07-24
Vibrio Cholerae O139 Conjugate Vaccines
App 20070166315 - Szu; Shousun Chen ;   et al.
2007-07-19
Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi
App 20060204515 - Ben-Menachem; Gil ;   et al.
2006-09-14
Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
App 20060134143 - Schneerson; Rachel ;   et al.
2006-06-22
Methods for preparing immunogenic conjugates
App 20050271675 - Schneerson, Rachel ;   et al.
2005-12-08
Recombinant toxin A and toxin B protein carrier for polysaccharide conjugate vaccines
App 20050202042 - Wilkins, Tracy D. ;   et al.
2005-09-15
Vaccines against Escherichia coli O157 infection
App 20050158339 - Szu, Shousun Chen ;   et al.
2005-07-21
Antimultiorganism Glycoconjugate vaccine
App 20050158346 - Kubler-Kielb, Joanna ;   et al.
2005-07-21
Vaccines against escherichia coli O157 infection
App 20050152922 - Szu, Shousun Chen ;   et al.
2005-07-14
Vaccines against Escherichia coli O157 infection
Grant 6,858,211 - Szu , et al. February 22, 2
2005-02-22
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
App 20040223973 - Kossaczka, Zuzana ;   et al.
2004-11-11
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
Grant 6,797,275 - Kossaczka , et al. September 28, 2
2004-09-28
Lipooligosaccharide-based vaccine for prevention of Moraxella (Branhamella) catarrhalis infections in humans
App 20040115214 - Gu, Xin-Xing ;   et al.
2004-06-17
Methods for preparing bacillus anthracis protective antigen for use in vaccines
App 20040076638 - Shiloach, Joseph ;   et al.
2004-04-22
Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
Grant 6,685,949 - Gu , et al. February 3, 2
2004-02-03
Immunogenic polysaccharide-protein conjugates containing poly .alpha.(2.fwdarw.8), .alpha.(2.fwdarw.9) NeuNAc capsular polysaccharides
Grant 6,632,437 - Schneerson , et al. October 14, 2
2003-10-14
Conjugate vaccine for nontypeable Haemophilus influenzae
Grant 6,607,725 - Gu , et al. August 19, 2
2003-08-19
Conjugate vaccine for nontypeable haemophilus influenzae
App 20020001589 - Gu, Xin-Xing ;   et al.
2002-01-03
Conjugate vaccine for nontypeable Haemophilus influenzae
Grant 6,207,157 - Gu , et al. March 27, 2
2001-03-27
Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
Grant 5,445,817 - Schneerson , et al. August 29, 1
1995-08-29
Polysaccharide-protein conjugates
Grant 5,204,098 - Szu , et al. April 20, 1
1993-04-20
Iodine sterilization of deionized water in semiconductor processing
Grant 4,935,064 - Robbins , et al. June 19, 1
1990-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed